Your session is about to expire
← Back to Search
Vitamin
Vitamin D for Vitamin D Deficiency
Phase 2
Waitlist Available
Led By Mario Chojkier, MD
Research Sponsored by Veterans Medical Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
Study Summary
Chronic liver diseases are associated with inflammation. The investigators postulate that Vitamin D may modulate inflammation. Thus the investigators will study the effect of Vitamin D replacement in patients with Hepatitis C infection and Vitamin D deficiency.
Eligible Conditions
- Vitamin D Deficiency
- Hepatitis C
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Macrophage activation
Secondary outcome measures
Liver injury
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Vitamin DActive Control1 Intervention
Administration of 500,000 IU Vitamin D orally on Day 1
Group II: PlaceboPlacebo Group1 Intervention
Placebo will be given on Day 1 orally
Find a Location
Who is running the clinical trial?
Veterans Medical Research FoundationLead Sponsor
43 Previous Clinical Trials
4,910 Total Patients Enrolled
Mario Chojkier, MDPrincipal InvestigatorUniversity of California, San Diego
1 Previous Clinical Trials
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger